Aptorum Group Limited Class A Ordinary Shares
APMAptorum Group Limited is a biopharmaceutical company focused on developing and commercializing innovative therapies in areas such as infectious diseases, oncology, and metabolic disorders. The company leverages its expertise in drug discovery and development, primarily through its research and development subsidiaries, to bring novel treatments to market. Based in Hong Kong, Aptorum aims to address unmet medical needs through its pipeline of clinical-stage and preclinical products.
Company News
DiamiR Biosciences received New York State approval for its APOE Genotyping test, which identifies genetic variants associated with late-onset Alzheimer's disease risk. The company is set to merge with Aptorum Group in an all-stock transaction expected to close in Q4 2025.
Aptorum Group Limited and DiamiR Biosciences have signed a definitive merger agreement, where DiamiR will become a wholly-owned subsidiary of Aptorum. The all-stock transaction will result in DiamiR shareholders owning approximately 70% of the combined company, with the merger expected to close in Q4 2025.
Aptorum Group, a clinical-stage biopharmaceutical company, announced a $3 million registered direct offering of 1,535,000 Class A Ordinary Shares at $2.00 per share. The offering is expected to close on January 3, 2025, subject to customary closing conditions.
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. Limbach said it sees FY24 revenue of $510 million to $530 million, versus market estimates of $541.1 million. Limbach shares dipped 14.7% to $42.42 o...
U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P 500 also rose, gaining, 0.14% to 5,172.33. Check This Out: Tesla To $165? Here Are 10 Top Analyst Forecasts For Thursday  Leading and Lagging Se...
